Literature DB >> 8917375

Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.

K el-Bayoumy1, P Upadhyaya, D H Desai, S Amin, D Hoffmann, E L Wynder.   

Abstract

In this study we examined whether chemopreventive agents that had each been shown to be effective against lung tuorigenesis induced in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were more effective when applied together as a "cocktail" than as individual compounds. Groups of A/J mice were fed a diet containing 1,4-phenylenebis(methylene)selenocyanate (p-XSC; 5 ppm as selenium, 0.0005%), phenethyl isothiocyanate (PEITC; 0.008%), indole-3-carbinol (I3C; 0.18%), d-limonene (d-L, 0.63%), or a mixture of all four at the above levels. Mice were fed experimental diets (AIN-76A plus a chemopreventive agent, or a mixture of the four chemopreventive agents) for 17 weeks. One week after beginning the experimental diets, the animals received a single i.p. injection of 10 mumol NNK (2.07 mg) in 0.1 ml saline. Sixteen weeks after the NNK application the bioassay was terminated. Dietary p-XSC, PEITC, I3C, d-L, and their admixture reduced significantly the number of lung tumors per mouse from 8.1 in the positive control to 3.2, 3.7, 4.9, 2.4, and 2.5, respectively (p < 0.05). The inhibition of lung tumor multiplicity in mice fed either the mixture or d-L alone was also significantly stronger than in those fed the diet containing only I3C. However, neither individual agents nor their mixture had a measurable effect on lung tumor incidence. Although the effect of the mixture on lung tumor incidence in this assay remained imperfect, this preliminary investigation provides some basis for the future design of chemoprevention studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917375

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.

Authors:  Michael A Pereira; Blake M Warner; Thomas J Knobloch; Christopher M Weghorst; Ronald A Lubet; Vernon E Steele; Bruce C Casto
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

2.  Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.

Authors:  Yasunari Takada; Michael Andreeff; Bharat B Aggarwal
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian population.

Authors:  Nathan R Jones; Thomas E Spratt; Arthur S Berg; Joshua E Muscat; Philip Lazarus; Carla J Gallagher
Journal:  Cancer Epidemiol       Date:  2010-09-21       Impact factor: 2.984

4.  Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.

Authors:  Fekadu Kassie; Stephen Kalscheuer; Ilze Matise; Linan Ma; Tamene Melkamu; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

5.  Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid.

Authors:  Robyn L Poerschke; Michael R Franklin; Philip J Moos
Journal:  Toxicol In Vitro       Date:  2008-08-15       Impact factor: 3.500

6.  Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol.

Authors:  Fekadu Kassie; Ilze Matise; Mesfin Negia; Pramod Upadhyaya; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

7.  Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects.

Authors:  Gregory A Reed; Jean M Sunega; Debra K Sullivan; John C Gray; Matthew S Mayo; James A Crowell; Aryeh Hurwitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

Review 8.  Molecular targets of isothiocyanates in cancer: recent advances.

Authors:  Parul Gupta; Bonglee Kim; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Mol Nutr Food Res       Date:  2014-02-10       Impact factor: 5.914

Review 9.  Selenium and lung cancer: a systematic review and meta analysis.

Authors:  Heidi Fritz; Deborah Kennedy; Dean Fergusson; Rochelle Fernandes; Kieran Cooley; Andrew Seely; Stephen Sagar; Raimond Wong; Dugald Seely
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.